Quarterly report pursuant to Section 13 or 15(d)

Inventory

v3.24.1.u1
Inventory
3 Months Ended
Feb. 29, 2024
Inventory Disclosure [Abstract]  
Inventory

Note 3 – Inventory

Inventory is comprised of public cord blood banking specimens, collection kits, finished goods, work-in-process and raw materials. Collection kits are used in the collection and processing of umbilical cord blood and cord tissue stem cells, finished goods include products purchased or assumed for resale and for the use in the Company’s processing and storage service. Inventory in the

Public Cord Blood Bank includes finished goods that are specimens that are available for resale. The Company considers Public Cord Blood Inventory in the Public Cord Blood Bank that has not completed all testing to determine viability to be work in process.

The components of inventory at February 29, 2024 and November 30, 2023 are as follows:

 

 

 

As of
February 29, 2024

 

 

As of
November 30, 2023

 

Raw materials

 

$

 

 

$

 

Work-in-process

 

 

331,417

 

 

 

341,692

 

Work-in-process – Public Bank

 

 

 

 

 

 

Finished goods

 

 

38,397

 

 

 

48,045

 

Finished goods – Public Bank

 

 

5,562,305

 

 

 

5,599,238

 

Collection kits

 

 

54,739

 

 

 

47,739

 

Inventory reserve

 

 

(7,718

)

 

 

(7,718

)

Total inventory

 

$

5,979,140

 

 

$

6,028,996